These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 26585610)
1. Letter to the editor. Commentary to the article: LaMoreaux B, Barbar-smiley F, Ardoin S, Madhoun H. Two cases of thrombosis in patients with antiphospholipid antibodies during treatment of immune thrombocytopenia with romiplostin, a thrombopoietin receptor agonist. Semin Arthritis Rheum 2015 Jul 29.pii: S0049-0172(15)00196-1. DOI:10.1016/j.semarthrit.2015.07-008. [Epub ahead of print]. Borrell H; Nolla JM; Narváez J Semin Arthritis Rheum; 2016 Apr; 45(5):e16. PubMed ID: 26585610 [No Abstract] [Full Text] [Related]
2. Commentary on the article: Hughes M & Pauling JD. Exploring the patient experience of digital ulcers in systemic sclerosis. Semin Arthritis Rheum. 2018 Aug 11. pii: S0049-0172(18)30354-8. doi: 10.1016/j.semarthrit.2018.08.001. [Epub ahead of print] Review. Kocher A; Stamm T Semin Arthritis Rheum; 2019 Aug; 49(1):e9. PubMed ID: 30660383 [No Abstract] [Full Text] [Related]
3. Two cases of thrombosis in patients with antiphospholipid antibodies during treatment of immune thrombocytopenia with romiplostim, a thrombopoietin receptor agonist. LaMoreaux B; Barbar-Smiley F; Ardoin S; Madhoun H Semin Arthritis Rheum; 2016 Feb; 45(4):e10-2. PubMed ID: 26329147 [TBL] [Abstract][Full Text] [Related]
4. [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study]. Weber E; Moulis G; Mahévas M; Guy C; Lioger B; Durieu I; Hunault M; Ramanantsoa M; Royer B; Default A; Pérault-Pochat MC; Moachon L; Bernard N; Bardy G; Jonville-Bera AP; Geniaux H; Godeau B; Cathébras P Rev Med Interne; 2017 Mar; 38(3):167-175. PubMed ID: 27793553 [TBL] [Abstract][Full Text] [Related]
5. Portal vein thrombosis as complication of romiplostim treatment in a cirrhotic patient with hepatitis C-associated immune thrombocytopenic purpura. Dultz G; Kronenberger B; Azizi A; Mihm U; Vogl TJ; Sarrazin U; Sarrazin C; Zeuzem S; Hofmann WP J Hepatol; 2011 Jul; 55(1):229-32. PubMed ID: 21310200 [TBL] [Abstract][Full Text] [Related]
6. [Antiphospholipid antibodies and the risk of thrombosis: a comparative survey between chronic immune thrombocytopenia and primary antiphospholipid syndrome]. Moulis G; Delavigne K; Huguet F; Fortenfant F; Beyne-Rauzy O; Adoue D Rev Med Interne; 2011 Dec; 32(12):724-9. PubMed ID: 21864953 [TBL] [Abstract][Full Text] [Related]
7. Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis. Atsumi T; Furukawa S; Amengual O; Koike T Lupus; 2005; 14(7):499-504. PubMed ID: 16130503 [TBL] [Abstract][Full Text] [Related]
8. A case of acute stent thrombosis during treatment with the thrombopoietin receptor agonist peptide--romiplostim. Rayoo R; Sharma N; van Gaal WJ Heart Lung Circ; 2012 Mar; 21(3):182-4. PubMed ID: 21963397 [TBL] [Abstract][Full Text] [Related]
9. Thrombopoietin receptor agonists: a new immune modulatory strategy in immune thrombocytopenia? Schifferli A; Kühne T Semin Hematol; 2016 Apr; 53 Suppl 1():S31-4. PubMed ID: 27312161 [TBL] [Abstract][Full Text] [Related]
10. Two cases of autoimmune thrombocytopenic purpura associated with antiphospholipid antibodies. Moccia F Ann Ital Med Int; 1999; 14(2):114-7. PubMed ID: 10399373 [TBL] [Abstract][Full Text] [Related]
11. [Romiplostim: an advance in the treatment of idiopathic thrombocytopenic purpura]. Mingot Castellano ME Methods Find Exp Clin Pharmacol; 2010 Dec; 32 Suppl A():39-43. PubMed ID: 21381287 [TBL] [Abstract][Full Text] [Related]
12. Lack of association between antiphospholipid antibodies and thrombocytopenia in patients with Wegener's granulomatosis. Meyer MF; Schnabel A; Schatz H; Gross WL Semin Arthritis Rheum; 2001 Aug; 31(1):4-11. PubMed ID: 11503134 [TBL] [Abstract][Full Text] [Related]
13. Thrombopoietin levels in systemic lupus erythematosus are linked to inflammatory cytokines, but unrelated to thrombocytopenia or thrombosis. Lu C; Nossent J Lupus; 2015 Jan; 24(1):18-24. PubMed ID: 25117655 [TBL] [Abstract][Full Text] [Related]
14. Antiphospholipid antibody-associated thrombocytopenia and the paradoxical risk of thrombosis. Fortea J; Obach V; Cervera R; Gamarra AI Lupus; 2006; 15(1):58. PubMed ID: 16482749 [No Abstract] [Full Text] [Related]
15. Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics. Liebman HA; Pullarkat V Hematology Am Soc Hematol Educ Program; 2011; 2011():384-90. PubMed ID: 22160062 [TBL] [Abstract][Full Text] [Related]
16. Use of Thrombopoietin-Receptor Agonist in CVID-Associated Immune Thrombocytopenia. Carrabba M; Barcellini W; Fabio G J Clin Immunol; 2016 Jul; 36(5):434-6. PubMed ID: 27072856 [No Abstract] [Full Text] [Related]